Clinical trials
Phase 2/3 Urinary Bladder Neoplasms trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Recruiting | 2 |
| Active, not recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 2 |
| Bioniche Life Sciences Inc. | 1 |
| CG Oncology, Inc. | 1 |
| Daiichi Sankyo | 1 |
| Endo USA Inc., a Keenova Therapeutics Company | 1 |
| ImmunityBio, Inc. | 1 |
| National Cancer Institute (NCI) | 1 |
| University of Washington | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Urinary Bladder Neoplasms | 9 |
| Carcinoma, Transitional Cell | 4 |
| Carcinoma in Situ | 3 |
| Adenoviridae Infections | 1 |
| Mycobacterium Infections | 1 |
| Neoplasm Metastasis | 1 |
| Neoplasm Recurrence, Local | 1 |
| Neoplasms | 1 |
| Non-Muscle Invasive Bladder Neoplasms | 1 |
| Virus Diseases | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.